Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells

Neuroscience Letters

Volumn 290, Issue 3, 2000, Pages 201-204

  Park, Myung Jin ^a   Park, In Chul ^a   Hur, Jin Heang ^a   Rhee, Chang Hun ^a   Choe, Tae Boo ^b   Yi, Dong Hee ^b   Hong, Seok Il ^a   Lee, Seung Hoon ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Glioblastoma; Invasion; Matrix metalloproteinases; Protein kinase C; Tissue inhibitors of metalloproteinases

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME REGULATION; ENZYME RELEASE; GLIOBLASTOMA; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; PHORBOL ESTERS; PROTEIN KINASE C; TETRADECANOYLPHORBOL ACETATE; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED;

EID: 0034284266     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01358-6     Document Type: Article

References (19)

1. Azzam H.S., Thompson E.W. Collagen-induced activation of the M(r) 72,000 type IV collagenases in normal and malignant human fibroblastoid cells. Cancer Res. 52:1992;4540-4544.
2. Basset P., Okada A., Chenard M.P., Kannan R., Stoll I., Anglard P., Bellocq J.P., Rio M.C. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutical implications. Matrix Biol. 15:1997;535-541.
3. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., De Carlo A., Engler J.A. Matrix metallproteinases: a review. Crit. Rev. Oral. Biol. Med. 4:1993;197-250.
4. Davies B., Waxman J., Wasan H., Abel P., Williams G., Karausz T., Neal D., Thomas D., Hanby A., Balkwill F. Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 53:1993;5365-5369.
5. Emonard H.P., Remacle A.G., Noel A.C., Grmaud J.A., Stetler-Stevenson W.G., Foidart J.M. Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res. 52:1992;5845-5848.
6. Foda H.D., George S., Conner C., Dres M., Tomkins D.C., Zucker S. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab. Invest. 74:1996;538-545.
7. Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H.J., Johannes F.J. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase C isozymes. FEBS Lett. 392:1996;77-80.
8. Heppner K.J., Matrisian L.M., Jensen R.A., Rodgers W.H. Expression of most MMP family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149:1996;273-282.
9. Johnsen M., Lund L.R., Romer J., Almholt K., Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 10:1998;667-671.
10. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 64:1991;327-336.
11. Matrisian L.M. The matrix-degrading metalloproteinases. Bioassays. 14:1992;455-463.
12. Mignatti P., Rifkin D.B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:1993;161-195.
13. Murphy G., Willenbrock F., Ward R.V., Cockett M.I., Eaton D., Docherty A.J. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem. J. 283:1992;637-641.
14. Overall C.M., Sodek J. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinses. J. Biol. Chem. 265:1990;21141-21151.
15. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:1994;61-65.
16. Stetler-Stevenson W.G. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev. 9:1990;289-303.
17. Woessner J.F. Jr. Matrix metalloproteases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
18. Woessner J.F. The matrix metalloproteinases family. Park W.C., Mecham R.P. Matrix metalloproteinases. 2000;1-14 Academic Press, San Diego.
19. Zhang W., Law R.E., Hinton D.R., Couldwell W.T. Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor. Cancer Lett. 120:1997;31-38.